SureTrader Nadex Advertisement
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611
Search This Board: 
Last Post: 2/23/2017 2:39:26 PM - Followers: 98 - Board type: Free - Posts Today: 0



About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.


Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values


BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.


BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.


BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the online website. Audited financial reports are available quarterly.

Company Structure Details

Watch Jeremy Miller on Fox News!

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>

<iframe width="560" height="315" src="" frameborder="0" allowfullscreen></iframe>


BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673) 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#7795   194K Buy just went through :) DREAM BIG 02/23/17 02:39:25 PM
#7794   Thanks for posting the PR Dream. This Fido 02/23/17 08:02:49 AM
#7793   BioCorRx Provides Preclinical Study Update on BICX101 Development DREAM BIG 02/23/17 07:56:16 AM
#7792   That was probably a T Trade. It's when Pip611 02/22/17 07:26:33 PM
#7791   No it will open at the closing price JB51 02/22/17 06:19:59 PM
#7790   Well apparently OTCs can trade whenever because they Kizersosae 02/22/17 06:02:03 PM
#7789   What's up with that huge after hours trade Kizersosae 02/22/17 04:39:38 PM
#7788   Last year BICX was hovering around .02+ for chakalalaBoom 02/22/17 01:25:24 PM
#7787   I think the author is just comparing them Pip611 02/22/17 12:02:07 PM
#7786   All Stocks mentioned in Article has a PPS DREAM BIG 02/22/17 11:17:41 AM
#7785   Thanks PIP, good article... ya this ASK at Kizersosae 02/22/17 11:14:48 AM
#7784   More BICX Press! Pip611 02/22/17 10:46:54 AM
#7783   At least we're going in the right direction!! Up JB51 02/22/17 10:31:26 AM
#7782   Some good buys @0.0719 ....150K just went through DREAM BIG 02/22/17 10:25:43 AM
#7781   My guess is it's that old board member Pip611 02/21/17 04:54:07 PM
#7780   Yes that would not be good. If it JB51 02/21/17 04:47:34 PM
#7779   Hope it's not an insider with the animal Kizersosae 02/21/17 04:19:19 PM
#7778   Someone doing some big selling! JB51 02/21/17 04:16:21 PM
#7777   Maybe we have all the sellers out now JB51 02/21/17 10:56:56 AM
#7776   BioCorRx Announces the Appointment of Dr. Balbir S. DREAM BIG 02/21/17 10:34:28 AM
#7775   Dr Brar was given a more permanent job/promotion... Kizersosae 02/21/17 08:31:54 AM
#7774   Yes, I agree higher highs coming! Just need JB51 02/20/17 08:44:07 PM
#7773   And if it drops... well I just buy Kizersosae 02/20/17 08:35:21 PM
#7772   I have a feeling we are going to Pip611 02/20/17 07:45:07 PM
#7771   All in all a good week! Held JB51 02/17/17 05:25:12 PM
#7770   People are now maiming their pets to score Pip611 02/17/17 02:48:43 PM
#7769 Stigsypoo 02/17/17 02:42:44 PM
#7768   Found this today, captainhook002 02/17/17 09:52:02 AM
#7767   I bet Trump puts Christie in charge battling Pip611 02/17/17 08:16:50 AM
#7766   The president met with Chris Christie this week Stigsypoo 02/17/17 06:35:26 AM
#7765   Ya hopefully the Dec. 22 research comes back Kizersosae 02/16/17 09:12:48 PM
#7764   News should be coming in next two weeks, JB51 02/16/17 02:29:10 PM
#7763   click on your portfolio and then streaming quotes. Pip611 02/16/17 11:01:22 AM
#7762   I have etrade too !! how can I DREAM BIG 02/16/17 10:55:48 AM
#7761   Oh... Scott Trade is what I use... it's Kizersosae 02/16/17 10:26:03 AM
#7760   I get it free with my etrade account. Pip611 02/16/17 10:23:11 AM
#7759   Do you pay for level 2 or is Kizersosae 02/16/17 10:02:52 AM
#7758   nice bid support in the .07 already today. Pip611 02/16/17 09:59:41 AM
#7757   Just waiting on good news... I like were Kizersosae 02/15/17 10:31:03 AM
#7756   Yes I think we're up and away to JB51 02/14/17 12:29:40 PM
#7755   we have been stuck in the .03-.04 range Pip611 02/14/17 11:47:35 AM
#7754   PPS Adjustment day ? DREAM BIG 02/14/17 09:57:31 AM
#7753   I get their emails, it would have been Fido 02/13/17 09:33:22 PM
#7752   We made it on SeekingAlpha boys! Getting Pip611 02/13/17 07:34:59 PM
#7751   Yes nice to see some positive news, just JB51 02/13/17 06:57:51 PM
#7750   Where is this posted? Hopefully it gets distributed Kizersosae 02/13/17 06:28:55 PM
#7749   Nice update and thanks for posting it. Fido 02/13/17 05:13:35 PM
#7748   BioCorRx (BICX) Update: FDA Results Imminent DREAM BIG 02/13/17 04:12:59 PM
#7747   Studies show a correlation between cost and scarcity Stigsypoo 02/13/17 02:51:23 PM
#7746   google the first sentence of the post - Pip611 02/13/17 02:38:17 PM